BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Galli J, Cammarota G, De Corso E, Agostino S, Cianci R, Almadori G, Paludetti G. Biliary laryngopharyngeal reflux: a new pathological entity. Current Opinion in Otolaryngology & Head & Neck Surgery 2006;14:128-32. [DOI: 10.1097/01.moo.0000193198.40096.be] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Sasaki CT, Hajek M, Doukas SG, Vageli DP. The role of bile reflux and its related NF-κB activated pathway in progression of hypopharyngeal squamous cell cancer. Oral Oncol 2020;105:104668. [PMID: 32247988 DOI: 10.1016/j.oraloncology.2020.104668] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
2 Lechien JR, Dapri G, Dequanter D, Rodriguez Ruiz A, Marechal MT, De Marrez LG, Saussez S, Fisichella PM. Surgical Treatment for Laryngopharyngeal Reflux Disease: A Systematic Review. JAMA Otolaryngol Head Neck Surg. 2019;145:655-666. [PMID: 31046069 DOI: 10.1001/jamaoto.2019.0315] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
3 Doukas SG, Vageli DP, Sasaki CT. NF-κB inhibition reverses acidic bile-induced miR-21, miR-155, miR-192, miR-34a, miR-375 and miR-451a deregulations in human hypopharyngeal cells. J Cell Mol Med 2018;22:2922-34. [PMID: 29516639 DOI: 10.1111/jcmm.13591] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
4 Doukas PG, Vageli DP, Doukas SG, Sasaki CT. Temporal characteristics of NF-κB inhibition in blocking bile-induced oncogenic molecular events in hypopharyngeal cells. Oncotarget 2019;10:3339-51. [PMID: 31164956 DOI: 10.18632/oncotarget.26917] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
5 Lechien JR, Bobin F, Muls V, Thill MP, Horoi M, Ostermann K, Huet K, Harmegnies B, Dequanter D, Dapri G, Maréchal MT, Finck C, Rodriguez Ruiz A, Saussez S. Validity and reliability of the reflux symptom score. Laryngoscope 2020;130:E98-E107. [PMID: 30983002 DOI: 10.1002/lary.28017] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 12.3] [Reference Citation Analysis]
6 Lechien JR, Akst LM, Hamdan AL, Schindler A, Karkos PD, Barillari MR, Calvo-Henriquez C, Crevier-Buchman L, Finck C, Eun YG, Saussez S, Vaezi MF. Evaluation and Management of Laryngopharyngeal Reflux Disease: State of the Art Review. Otolaryngol Head Neck Surg. 2019;160:762-782. [PMID: 30744489 DOI: 10.1177/0194599819827488] [Cited by in Crossref: 95] [Cited by in F6Publishing: 77] [Article Influence: 31.7] [Reference Citation Analysis]
7 Sone M, Kato T, Suzuki Y, Arao H, Sugiyama K, Ishida K, Izawa K, Takasu A, Nakashima T. Relevance and characteristics of gastroesophageal reflux in adult patients with otitis media with effusion. Auris Nasus Larynx 2011;38:203-7. [DOI: 10.1016/j.anl.2010.08.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
8 Zelenik K, Kajzrlikova IM, Vitek P, Urban O, Hanousek M, Kominek P. There is no correlation between signs of reflux laryngitis and reflux oesophagitis in patients with gastro-oesophageal reflux disease symptoms. Acta Otorhinolaryngol Ital 2017;37:401-5. [PMID: 29165435 DOI: 10.14639/0392-100X-1237] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
9 Naiboglu B, Durmus R, Tek A, Toros SZ, Egeli E. Do the laryngopharyngeal symptoms and signs ameliorate by empiric treatment in patients with suspected laryngopharyngeal reflux? Auris Nasus Larynx 2011;38:622-7. [DOI: 10.1016/j.anl.2011.01.010] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
10 Merati AL. Acute and Chronic Laryngitis. Cummings Otolaryngology - Head and Neck Surgery. Elsevier; 2010. pp. 883-8. [DOI: 10.1016/b978-0-323-05283-2.00064-1] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
11 Tokashiki R, Okamoto I, Funato N, Suzuki M. Rikkunshito improves globus sensation in patients with proton-pump inhibitor-refractory laryngopharyngeal reflux. World J Gastroenterol 2013; 19(31): 5118-5124 [PMID: 23964146 DOI: 10.3748/wjg.v19.i31.5118] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
12 Datta R, Datta K, Venkatesh MD. Laryngopharyngeal Reflux : Larynx on Fire. Med J Armed Forces India 2010;66:245-8. [PMID: 27408311 DOI: 10.1016/S0377-1237(10)80049-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Galli J, Settimi S, Salonna G, Mele DA, De Corso E, Paludetti G. Narrow Band Imaging for lingual tonsil hypertrophy and inflammation, in laryngo-pharyngeal reflux disease. Eur Arch Otorhinolaryngol 2020;277:819-25. [PMID: 31858222 DOI: 10.1007/s00405-019-05765-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
14 Lechien JR, Saussez S, Karkos PD. Laryngopharyngeal reflux disease: clinical presentation, diagnosis and therapeutic challenges in 2018. Current Opinion in Otolaryngology & Head & Neck Surgery 2018;26:392-402. [DOI: 10.1097/moo.0000000000000486] [Cited by in Crossref: 31] [Cited by in F6Publishing: 6] [Article Influence: 7.8] [Reference Citation Analysis]
15 Doukas PG, Vageli DP, Judson BL. The Role of PARP ‐1 and NF‐κB in Bile‐Induced DNA Damage and Oncogenic Profile in Hypopharyngeal Cells. The Laryngoscope. [DOI: 10.1002/lary.30284] [Reference Citation Analysis]
16 Lechien J, Mouawad F, Bobin F, Bartaire E, Crevier-buchman L, Saussez S. Review of management of laryngopharyngeal reflux disease. European Annals of Otorhinolaryngology, Head and Neck Diseases 2021;138:257-67. [DOI: 10.1016/j.anorl.2020.11.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Vageli DP, Doukas SG, Spock T, Sasaki CT. Curcumin prevents the bile reflux-induced NF-κB-related mRNA oncogenic phenotype, in human hypopharyngeal cells. J Cell Mol Med 2018;22:4209-20. [PMID: 29911313 DOI: 10.1111/jcmm.13701] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
18 De Corso E, Baroni S, Salonna G, Marchese M, Graziadio M, Di Cintio G, Paludetti G, Costamagna G, Galli J. Impact of bile acids on the severity of laryngo-pharyngeal reflux. Clin Otolaryngol 2021;46:189-95. [PMID: 32876387 DOI: 10.1111/coa.13643] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
19 Vageli DP, Prasad ML, Sasaki CT. Gastro-duodenal fluid induced nuclear factor-κappaB activation and early pre-malignant alterations in murine hypopharyngeal mucosa. Oncotarget 2016;7:5892-908. [PMID: 26745676 DOI: 10.18632/oncotarget.6824] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
20 Maqbool A, Ryan MJ. Gastroesophageal Reflux Disease and Aerodigestive Disorders. Curr Probl Pediatr Adolesc Health Care 2018;48:85-98. [PMID: 29571546 DOI: 10.1016/j.cppeds.2018.01.005] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Lechien JR, Muls V, Dapri G, Mouawad F, Eisendrath P, Schindler A, Nacci A, Barillari MR, Finck C, Saussez S, Akst LM, Sataloff RT. The management of suspected or confirmed laryngopharyngeal reflux patients with recalcitrant symptoms: A contemporary review. Clin Otolaryngol. 2019;44:784-800. [PMID: 31230417 DOI: 10.1111/coa.13395] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
22 De Corso E, Baroni S, Agostino S, Cammarota G, Mascagna G, Mannocci A, Rigante M, Galli J. Bile acids and total bilirubin detection in saliva of patients submitted to gastric surgery and in particular to subtotal Billroth II resection. Ann Surg 2007;245:880-5. [PMID: 17522513 DOI: 10.1097/01.sla.0000255574.22821.a1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
23 Mannelli G, Santoro R, Segala F, Surrenti E, Gallo O. Gastro-pharyngeal reflux and total laryngectomy. Increasing knowledge about its management. Am J Otolaryngol 2018;39:127-32. [PMID: 29307652 DOI: 10.1016/j.amjoto.2017.12.010] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
24 Vageli DP, Doukas SG, Doukas PG, Judson BL. Bile reflux and hypopharyngeal cancer (Review). Oncol Rep 2021;46:244. [PMID: 34558652 DOI: 10.3892/or.2021.8195] [Reference Citation Analysis]
25 Sasaki CT, Issaeva N, Vageli DP. In vitro model for gastroduodenal reflux-induced nuclear factor-kappaB activation and its role in hypopharyngeal carcinogenesis: Gastroduodenal reflux-induced NF-κB activation hypopharyngeal cancer. Head Neck 2016;38:E1381-91. [DOI: 10.1002/hed.24231] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
26 Sone M, Kato T, Nakashima T. Current concepts of otitis media in adults as a reflux-related disease. Otol Neurotol 2013;34:1013-7. [PMID: 23851353 DOI: 10.1097/MAO.0b013e318299aa52] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
27 Sasaki CT, Doukas SG, Costa J, Vageli DP. The Progressive Mutagenic Effects of Acidic Bile Refluxate in Hypopharyngeal Squamous Cell Carcinogenesis: New Insights. Cancers (Basel) 2020;12:E1064. [PMID: 32344873 DOI: 10.3390/cancers12051064] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
28 Sasaki CT, Doukas SG, Costa J, Vageli DP. Biliary reflux as a causal factor in hypopharyngeal carcinoma: New clinical evidence and implications. Cancer 2019;125:3554-65. [PMID: 31310330 DOI: 10.1002/cncr.32369] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
29 Lagergren J, Lindam A. Increased risk of laryngeal and pharyngeal cancer after gastrectomy for ulcer disease in a population-based cohort study. Br J Cancer 2012;106:1342-5. [PMID: 22453126 DOI: 10.1038/bjc.2012.72] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]